Stock A214150 CLASSYS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials CLASSYS Inc.

Equities

A214150

KR7214150005

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
37,950 KRW +0.26% Intraday chart for CLASSYS Inc. -2.19% +0.53%
2023 Tranche Update on CLASSYS Inc.'s Equity Buyback Plan announced on September 15, 2022. CI
2023 Tranche Update on CLASSYS Inc.'s Equity Buyback Plan announced on September 15, 2022. CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 910,756 996,521 1,216,677 1,185,127 2,420,323 2,399,288 - -
Enterprise Value (EV) 2 875.6 927.8 1,204 1,161 2,420 2,257 2,146 2,027
P/E ratio 26.6 x 26.1 x 27.8 x 15.8 x 32.8 x 24.9 x 20.3 x 17 x
Yield 0.33% 0.39% 0.35% 0.63% - 0.33% 0.39% 0.45%
Capitalization / Revenue 11.2 x 13 x 12.1 x 8.36 x 13.4 x 10.7 x 8.78 x 7.44 x
EV / Revenue 10.8 x 12.1 x 12 x 8.18 x 13.4 x 10 x 7.85 x 6.29 x
EV / EBITDA 20.3 x 21.7 x 22.2 x 16.1 x 25.9 x 19 x 14.6 x 11.7 x
EV / FCF 26.7 x 24.9 x 322 x 42.6 x - 24.9 x 21.1 x 16.9 x
FCF Yield 3.75% 4.02% 0.31% 2.35% - 4.02% 4.73% 5.9%
Price to Book 10.1 x 8.05 x 7.43 x 5.19 x - 6.25 x 4.81 x 3.73 x
Nbr of stocks (in thousands) 64,364 64,709 64,717 64,409 64,115 63,222 - -
Reference price 3 14,150 15,400 18,800 18,400 37,750 37,950 37,950 37,950
Announcement Date 06/02/20 03/02/21 15/02/22 15/02/23 14/02/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 81.13 76.46 100.6 141.8 180.1 225.2 273.4 322.4
EBITDA 1 43.11 42.69 54.24 72.25 93.6 119.1 147.1 172.9
EBIT 1 41.69 40.61 51.71 68.88 89.6 115.7 142.8 168.6
Operating Margin 51.38% 53.11% 51.41% 48.57% 49.75% 51.4% 52.21% 52.29%
Earnings before Tax (EBT) 1 41.73 39.29 55.62 96.76 93.8 124.2 153.7 180.3
Net income 1 33.39 38.16 42.89 75.38 74.2 98.35 120.2 143.3
Net margin 41.16% 49.91% 42.63% 53.16% 41.2% 43.68% 43.95% 44.46%
EPS 2 531.0 589.0 676.0 1,165 1,152 1,527 1,867 2,239
Free Cash Flow 3 32,841 37,333 3,739 27,273 - 90,743 101,500 119,615
FCF margin 40,478.45% 48,826.57% 3,716.88% 19,233.09% - 40,298% 37,124.39% 37,106.97%
FCF Conversion (EBITDA) 76,182.1% 87,448.02% 6,894.11% 37,746.93% - 76,203.16% 68,981.36% 69,197.41%
FCF Conversion (Net income) 98,345.33% 97,821.19% 8,718.33% 36,181.52% - 92,265.23% 84,472.72% 83,456.94%
Dividend per Share 2 46.00 60.00 66.00 116.0 - 126.4 146.5 171.5
Announcement Date 06/02/20 03/02/21 15/02/22 15/02/23 14/02/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 24.47 25.32 35.38 32.68 33.27 40.47 38.97 45.9 48.25 47 48.16 57.52 59.54 61.66 57.7
EBITDA 1 - - - - 18.29 20.3 20.88 24.18 - 23 26.4 30 33.7 32.6 -
EBIT 1 13.33 11.43 16.7 15.26 17.48 19.43 19.89 23.15 24.66 21.9 24.6 28.62 31.06 31.06 31.2
Operating Margin 54.48% 45.16% 47.21% 46.69% 52.54% 48.01% 51.04% 50.43% 51.12% 46.6% 51.08% 49.76% 52.17% 50.37% 54.07%
Earnings before Tax (EBT) 1 15.88 11.23 16.62 17.53 22.14 40.46 23.13 24.65 27.77 18.3 28 31.17 34.33 33.83 33.8
Net income 1 12.52 9.68 12.82 13.81 18.71 30.04 18.78 18.56 21.19 15.7 21.77 24.72 25.8 26.13 29
Net margin 51.19% 38.23% 36.22% 42.25% 56.25% 74.23% 48.17% 40.44% 43.93% 33.4% 45.2% 42.97% 43.33% 42.38% 50.26%
EPS - - - - - - - - - 244.0 - - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 10/11/21 15/02/22 13/05/22 09/08/22 09/11/22 15/02/23 10/05/23 11/08/23 07/11/23 14/02/24 - - - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 35.2 68.7 13 24.6 - 142 253 373
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 2 32,841 37,333 3,739 27,273 - 90,743 101,500 119,615
ROE (net income / shareholders' equity) 47.8% 36.1% 29.9% 38.3% 28.9% 28.8% 26.9% 25.1%
ROA (Net income/ Total Assets) 35% 30.4% 24.8% 22.7% - 22.7% 21.7% 21.2%
Assets 1 95.35 125.6 173.2 331.4 - 433.3 555 676.9
Book Value Per Share 3 1,407 1,913 2,530 3,549 - 6,075 7,887 10,164
Cash Flow per Share 3 621.0 589.0 561.0 846.0 - 1,649 1,730 2,110
Capex 1 6.19 0.79 32.6 27.5 - 8.9 8.02 7.25
Capex / Sales 7.63% 1.04% 32.43% 19.38% - 3.95% 2.93% 2.25%
Announcement Date 06/02/20 03/02/21 15/02/22 15/02/23 14/02/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for CLASSYS Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
37,950 KRW
Average target price
44,889 KRW
Spread / Average Target
+18.28%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
CLASSYS INC. Stock CLASSYS Inc.
+0.53% 1.74B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.15% 220B
DANAHER CORPORATION Stock Danaher Corporation
+6.60% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+9.86% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+24.32% 107B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.95% 63.05B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.04% 51.74B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.47B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-1.43% 40.91B
RESMED, INC. Stock ResMed, Inc.
+24.40% 31.91B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. A214150 Stock
  4. Financials CLASSYS Inc.